Patients/Clinicians

Zelos is developing an innovative portfolio of complementary bone disease therapies covering osteoporosis, fracture repair, spine fusion and renal bone disease. Our focus on bone disease allows us to efficiently leverage our expertise to rapidly advance bone formation agents – specifically PTH analogs -  through development for each indication.
 
For more information on Zelos’ clinical trials, please visit:
 
www.clinicaltrials.gov

To review published scientific papers on Zelos' technology, click here.